Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemetrexed injection (Shilpa)
pemetrexed disodium · Shilpa Medicare
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
An IV solution for specified first-line, maintenance and post-chemotherapy nonsquamous NSCLC uses and initial use with cisplatin for malignant pleural mesothelioma when curative surgery is unsuitable.
LAMPGEN ANALYSIS
Why it matters
The new solution presentation adds a preparation option for existing pemetrexed regimens.
What research teams should watch
Check molecular eligibility and the intended combination, then verify dilution, folate and vitamin B12 procedures.
PRIMARY RECORDS